mRNA Vaccines, Artificial Intelligence, CAR T Cells: Most-Read Cancer Currents Stories of 2022

Having trouble viewing this email? View it as a Web page.

`

Dear Cancer Currents subscriber, Keeping up with the constant advances in cancer research is like trying to climb a greased flagpole: It's pretty much impossible. That's particularly true given the diversity and breadth of the research being conducted. The remarkable extent of that research is on full display in our most-read Cancer Currents stories published in 2022. Not surprisingly, readers are still very interested in the advances being made in immunotherapy, as well as topics like improving cancer screening and the role of artificial intelligence in diagnosis and treatment. So, in case you missed them the first time around, here are our most-read stories of 2022 and some other noteworthy stories we've picked from the past year. We'd like to thank you for your continued support of Cancer Currents. If you find our reporting important or helpful, please share our stories with friends and colleagues and encourage them to subscribe. And, finally, in case you've ever wondered just who is responsible for this publication, you can now learn more about the team behind it. Wishing you a happy and healthy 2023, The Cancer Currents editorial team Top 5 Most-Read Stories Can mRNA Vaccines Help Treat Cancer? 01/20/2022   Colonoscopy after Positive FIT Test Cuts Risk of Colorectal Cancer Death 05/05/2022   Carvykti Approval Marks Second CAR T-Cell Therapy for Multiple Myeloma 03/30/2022   Can Artificial Intelligence Help See Cancer in New, and Better, Ways? 03/22/2022   Enhertu Improves Survival for Metastatic "HER2-Low" Breast Cancer 07/05/2022 Editors' Picks New Drugs Raise Old Questions about Treating Cancer during Pregnancy 05/25/2022   Study Adds to Debate about Screening for Melanoma 05/04/2022   Telehealth-Based Cancer Care Surged during COVID. Will It Continue? 03/09/2022   Meeting Cancer Survivors' Psychosocial Health Needs: A Conversation with Dr. Patricia Ganz 06/07/2022   Keto Molecule Offers Clue for Preventing Colorectal Cancer 06/02/2022   Disguising Cancer as an Infection Helps the Immune System Eliminate Tumors 07/22/2022   Air Is Life: The Navajo Nation's Historic Commercial Tobacco Ban 02/07/2022

 

Stay Connected with the National Cancer Institute
Chat with us: LiveHelp  Call us: 1-800-4-CANCER (1-800-422-6237) SUBSCRIBER SERVICES: Manage Subscriptions  |  Help

 

This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Cancer Institute · BG 9609 MSC 9760 · 9609 Medical Center Drive · Bethesda, MD 20892